Schema-Root.org logo

 

  cross-referenced news and research resources about

 ebola virus

Schema-Root.org logo
images:  google   yahoo YouTube
spacer

updated Wed. October 26, 2022

-
(CNN) One of the deadliest Ebola outbreaks in history continues to worsen in the Democratic Republic of Congo with as many as 319 people ...
The baby, who was admitted to an Ebola treatment center six days after birth, has recovered from the virus, medical officials say. Congolese are ...

As an Ebola outbreak in a conflict-plagued region of the Democratic Republic of the Congo (DRC) continues to spread after 4 months, there's a ...
As Ebola outbreak spreads in Congo, concern grows over supplies of ... That is massive in traditional Ebola outbreak terms, but still pales in ...
The Democratic Republic of Congo has what is now the second worst Ebola outbreak in world history. At least 245 people have died from ...
After nearly 5 months and now 426 cases, the Ebola outbreak in North Kivu and Ituri provinces of the Democratic Republic of the Congo (DRC) ...

(CNN) The Democratic Republic of Congo has kicked off the world's first multidrug randomized control trial to evaluate the effectiveness and ...
But how long that protection lasts remained an open question. A fast-acting, long-lasting vaccine given in a single dose would be an effective tool for controlling dangerous Ebola outbreaks. Vaccinating health care workers, for instance, could prevent the type of spread within hospitals that, in the early days ...
The Ebola virus destroyed more than human lives when it emerged in Guinea a few years ago—it also eroded agriculture in Guinea, Liberia, and Sierra Leone. Food shortages, trade restrictions, border controls, and rising food prices led many farmers to resort to desperate measures and eat the seeds they ...
An Ebola vaccine made by Merck has protected a group of volunteers for two years — the longest it has been shown to protect against the disease, according to a study published in Lancet Infectious Diseases. The context: "A fast-acting, long-lasting vaccine given in a single dose would be an effective tool ...
April 16th, 2018 – There were several Ebola virus vaccine candidates developed during the 2013–16 western Africa outbreak. These vaccines were reported in a previous study to be well tolerated and immunogenic. However, health officials questioned the longevity of immune responses induced by these ...
Along with causing 11,000 deaths, the 2014 to 2016 West Africa Ebola virus disease outbreak severely impacted health systems and cost Guinea, Liberia and Sierra Leone an estimated $2.8 billion. A key lesson in the response to this outbreak was the critical importance of engaging with and mobilising ...
Former President John Dramani Mahama has said that the outbreak of the Ebola virus in three West African countries affected tourism in several other West ... Mr Mahama noted that “when Ebola struck recently in three of our sister countries in the sub-region, it affected tourism arrivals in all our countries”.
Scientific evidence at the start of the last major Ebola epidemic in West Africa that suggested the virus would change exceptionally rapidly was probably due to methodological biases. This has been shown by scientists led by Tanja Stadler, a professor at ETH Zurich's Department of Biosystems Science and ...
The 2014-2016 West African Ebola outbreak was the deadliest in history, infecting more than 28,000 people and killing more than 11,000. While the number of people infected in the United States was low, it was covered extensively in the media, leading to widespread fear. Now, given the success of recent ...
Researchers were able to mutate Viral Protein 40 (VP40) in a way that changed the residues of the protein, blocking the budding and replication of Ebola virus in a model system. VP40 is a peripheral membrane protein that regulates viral budding from the plasma membrane. It interacts with a human ...
Dr Matthew Snape, Consultant Vaccinologist at the Oxford Vaccine Group, University of Oxford said: “The extraordinary response to the Ebola virus epidemic of 2013 to 2015 included rapid development of several potential vaccines against this deadly virus, many of which had their 'first in human' dose ...

University of Alberta researchers have found the Ebola polymerase (enzyme), which may lead to more effective research and better treatments for the often fatal infection, and other related viral diseases. "Our study reports the expression, purification and biochemical characterization of an active, ...
Thanks for visiting HeraldMailMedia.com. You're entitled to limited access of articles every 30 days. If you enjoy our site and want full access, we ask you to purchase an affordable subscription. Facebook · Twitter · Email; Print; Save. WINCHESTER, Va. — A "safety zone" has been set up for the care of a ...
Now, University of Guelph researchers have shown that an innovative antibody delivery method could offer an effective way to prevent and treat Ebola infection. “Our goal is to make an antibody-based therapy that can protect against all strains of Ebola, and potentially Marburg virus, as well,” says Prof.
"Our goal is to make an antibody-based therapy that can protect against all strains of Ebola, and potentially Marburg virus, as well," says Prof. Sarah Wootton, Department of Pathobiology, who, along with PhD student Laura van Lieshout, found a new way to fight Ebola. "It would be used to stop the spread ...
... who contracted Ebola to take a drug that wasn't yet approved. It's the latest salvo in a legal case that could have broader implications for the ongoing campaign to pass a federal “right-to-try 1” law, in which advocates are aiming to help dying patients get access to other drugs the FDA hasn't yet approved.
Sierra Leone was among the countries hardest hit by the December 2013 Ebola outbreak, along with Guinea and Liberia. It recorded more than 3 900 of the 11 300 deaths from the more than two-year epidemic, according to the World Health Organisation. The outbreak led to schools being closed between ...
A new study says more than 100,000 malaria cases went untreated in Liberia during the height of the Ebola crisis. The deadly virus spread in West Africa for two years beginning in 2014. The disease killed about 11,000 people. But it also severely affected basic health care services. Ebola kills about half of ...
We learned this in 2014, with the Ebola crisis. While Ebola is fairly hard to catch, it left more than 11,000 people dead — and served as an enormous wake-up call. Republicans and Democrats in Congress put down their partisan swords. Senator Lamar Alexander (R-TN) told a crowded hearing room on ...
ZMapp functions as a combination of 3 humanized antibodies produced in genetically-modified tobacco plants that target 3 Ebola glycoprotein epitopes. If it proves efficacious and safe in animal models, it could be on track to become the first Ebola treatment approved by the US Food and Drug ...
Bats provide a refuge for some of the most lethal viruses known, including Ebola, Marburg, Nipah and SARS. Now we may know why the animals tolerate these lethal viruses – and it's because flying is such hard work. Peng Zhou of the Wuhan Institution of Virology in China and his colleagues studied the ...
“Ebola's collateral effects on (Liberia's) health system likely caused more deaths than Ebola did directly,” the university said in a press release. One of the most pernicious effects of the virus was the infection of almost 300 medical staff in Liberia, according to World Health Organization (WHO) figures, limiting ...
More than 100,000 malaria cases went untreated when Liberia's health care system buckled under the 2014-2015 Ebola outbreak, according to a new study. The research, published in the journal PLOS Medicine, shows how the toll of the Ebola outbreak goes beyond the 11,000 killed in West Africa by the ...
Etta Roberts works as a nurse at the Kahweh clinic, a health centre to the east of Monrovia. She usually treats around 10 patients a day for malaria and scabies. The clinic's founder, Reginald Kahweh, funded the building of the centre after losing both his parents to Ebola, saying: "Everyone had to step up to ...
Based on the findings, the authors hypothesize that Ebola virus can persist in these tissues in human survivors, and that the virus may reach seminal fluid in men by infecting immune cells called tissue macrophages. However, it is unclear if the detection of Ebola virus RNA in semen documented in human ...
When the deadly Ebola virus appeared in the Democratic Republic of Congo last year, the first reported outbreak since 2014, a rapid-response health care team snuffed it out quickly. While any triumph over the lethal scourge should be commended, it's also an early warning sign for the United States in an ...
First appearing in Sudan and the Democratic Republic of Congo in 1976, Ebola has instilled fear wherever infections have emerged due to its high fatality rate ranging from 25% to 90%. Most recently, west Africa experienced a record-breaking outbreak in 2014-2016. The virus spreads via the bodily fluids ...
The outbreak was only identified as Ebola three months later, in March 2014, by which time it had killed 30 people. The contagion coursed through the towns and villages of Guinea, then Sierra Leone, Liberia, Nigeria, Senegal and Mali. Infections multiplied at a rapid rate, killing more than 11,000 people.
Emergency medical training happens all the time in our area, but an event today (Wednesday) was unusual. It involved a big plane and a big disease, the Ebola virus. This medical exercise started Wednesday morning in Boise, where a 747 took off, headed for Spokane. It was carrying a staff of medical ...
Scientific evidence at the start of the last major Ebola epidemic in West Africa that suggested the virus would change exceptionally rapidly was probably due to methodological biases. This has been shown by scientists led by Tanja Stadler, a professor at ETH Zurich's Department of Biosystems Science and ...
It's being led by Professor Yoshihiro Kawaoka who has studied the Ebola vaccine for more than a decade. "We currently have no treatment for Ebola and we have to come up with something," said Rebecca Moritz, who is a bio-safety expert with the University of Wisconsin. Ebola is a rare, and deadly virus, ...
A UW-Madison lab next month will start making a vaccine against Ebola virus, which killed thousands in west Africa from 2014 to 2016. ... near UW Hospital, will produce up to 1,000 doses of vaccine for the clinical trial, to be led by Yoshihiro Kawaoka, a campus virologist and expert on Ebola and influenza.
(CNN) The youngest survivor of the Ebola outbreak received her discharge certificate from the Beni Ebola Treatment Center on Wednesday, ...


 

news and opinion


 


 


 


 


schema-root.org

   human
    diseases
     infections
      viral
        ebola
          epidemic

viral infections:
        ebola
        flu
        hiv
        human papilloma
        rabies
        swine

cross-references for
ebola: